Cambridge Investment Research Advisors, Inc. - AIM IMMUNOTECH INC ownership

AIM IMMUNOTECH INC's ticker is AIM and the CUSIP is 00901B105. A total of 40 filers reported holding AIM IMMUNOTECH INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Cambridge Investment Research Advisors, Inc. ownership history of AIM IMMUNOTECH INC
ValueSharesWeighting
Q1 2023$9
-40.0%
20,340
-56.4%
0.00%
Q4 2022$15
-99.9%
46,679
-1.1%
0.00%
Q3 2022$27,000
-25.0%
47,178
+1.1%
0.00%
Q2 2022$36,000
-26.5%
46,6780.0%0.00%
Q1 2022$49,000
-47.9%
46,678
-0.0%
0.00%
Q3 2021$94,000
-6.0%
46,6790.0%0.00%
Q2 2021$100,000
-5.7%
46,6790.0%0.00%
-100.0%
Q1 2021$106,000
+45.2%
46,679
+14.7%
0.00%
Q4 2020$73,0000.0%40,679
+19.0%
0.00%
Q3 2020$73,00034,1790.00%
Other shareholders
AIM IMMUNOTECH INC shareholders Q2 2022
NameSharesValueWeighting ↓
XTX MARKETS LLC 11,019$20,0000.04%
Virtu Financial LLC 103,807$186,0000.02%
ACT WEALTH MANAGEMENT, LLC 10,000$18,0000.01%
SeaCrest Wealth Management, LLC 48,873$87,0000.01%
Arkadios Wealth Advisors 20,000$35,0000.01%
Traynor Capital Management, Inc. 14,777$26,0000.01%
GSA CAPITAL PARTNERS LLP 17,047$31,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 111,000$199,0000.00%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 20,200$36,0000.00%
Tower Research Capital LLC (TRC) 12,513$22,0000.00%
View complete list of AIM IMMUNOTECH INC shareholders